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Epstein–Barr virus (EBV) encoded small, non-coding, non-polyadenylated RNAs, known as EBERs are the
most abundantly expressed viral transcripts in latently EBV infected cells. We found the speciﬁc role of
EBERs in cell cycle progression, resistance against chemotherapeutic drug and cellular invasion in gastric
cancer cells in vitro. Ectopic expression of EBERs upregulates the expression of IL-6 and activate its
downstream STAT3, which is signiﬁcantly involved in downregulating the expression of cell cycle
inhibitor genes p21 and p27. Stable expression of EBERs regulates the activation of pFAK and pPAK1 and
the expression of anti-metastatic genes RhoGDI and KAI-1 in gastric cancer cells. In addition,
administration of neu-IL-6 antibody and dominant negative STAT3β reduces chemoresistance and
inhibits invasion of EBERs-expressing gastric cancer cells. Our results thus revealed a novel role of
EBERs in the coordination of IL-6-STAT3 signaling pathway to chemoresistance and cellular migration.
& 2013 Elsevier Inc. All rights reserved.Introduction
Epstein–Barr virus, an opportunistic pathogen of human γ-her-
pesvirinae family, is associated with several malignancies such as
Burkitt’s lymphoma, Hodgkin’s lymphoma, nasopharyngeal carci-
noma, gastric carcinoma and breast carcinoma (BenAyed-Guerfali
et al., 2011; Bonnet et al., 1999; Kieff et al., 2007). In all of the
malignancies EBV persists in one of its three different latent phases
where expression of viral genes are restricted to six EBV nuclear
antigens (EBNA-1,–2, -3A, -3B, -3C, and -LP), three latent membrane
proteins (LMP1, 2A and 2B), two relatively abundant small, non-
coding, non-polyadenylated, uncapped RNAs (EBER1 and EBER2),
and BamHI A rightward frame transcripts (BARTs), but in different
combinations (Kieff et al., 2007). EBV is found in about ∼10% of
gastric adenocarcinomas, where EBV displays type I latency phase
which includes the expression of EBERs, EBNA1, BARF0 and LMP2A
(Uozaki and Fukayama, 2008). EBERs are considered as reliable
markers for in situ hybridization to detect EBV infection in clinical
samples of gastric carcinoma (Tokunaga et al., 1993a, 1993b),
Hodgkin’s lymphoma (Wu et al., 1990) etc. EBERs have also been
detected in malignant cells of EBV-associated breast tumors (Bonnet
et al., 1999; Fina et al., 2001). Although EBERs are common to allll rights reserved.latency phases, signiﬁcantly little is known about the role of EBERs
particularly in epithelial cancer pathogenesis.
EBERs (EBER1 and EBER2) are transcribed by RNA polymerase III
into non-translated RNAs of 167 and 172 nucleotides, respectively,
and form stem-loop structures by intramolecular base-pairing,
giving rise to double-stranded RNA like structures (Rosa et al.,
1981). Stable expression of EBERs in EBV-negative Burkitt’s lym-
phoma (BL) cells contributes to the clonal proliferation in soft agar,
tumorigenicity in SCID mice, apoptosis-resistance and maintenance
of malignant phenotypes (Komano et al., 1999; Yamamoto et al.,
2000). EBERs were also shown to induce the expression of several
autocrine growth factors e.g. IL-10 in BL cells (Kitagawa et al., 2000;
Samanta et al., 2008), IGF-I in epithelial cells (Dutta et al., 2006;
Iwakiri et al., 2005), IL-9 in T lymphocytes (Yang et al., 2004) and IL-
6 in lymphoblastoid cell lines (LCLs) (Wu et al., 2007). EBERs exert
their biological functions through interactions with different cellu-
lar proteins including RNA-activated protein kinase (PKR) (Nanbo
et al., 2005), ribosomal protein 22 (L22) (Fok et al., 2006a; Houmani
et al., 2009; Toczyski et al., 1994), lupus erythematosis-associated
antigen (La) (Fok et al., 2006b; Lerner et al., 1981), retinoic acid-
inducible gene I (RIG-I) (Samanta et al., 2008, 2006) and AU-rich
element binding factor 1 (AUF1)/ heterogeneous nuclear ribonu-
cleoprotein D (hnRNP D) (Lee et al., 2012). In BL cells with type I
latency, EBERs activate RIG-I mediated IRF-3 signaling to induce
type I IFN (Samanta et al., 2006) and IL-10 (Samanta et al., 2008).
EBERs also inhibit phosphorylation of PKR, and thereby confer
apoptosis-resistance in BL cells (Gregorovic et al., 2011; Komano
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nasopharyngeal epithelial cells (Wong et al., 2005). EBER expression
has also been shown to regulate genes involved in cell growth and
cytoskeleton reorganization (Eilebrecht et al., 2008; Houmani et al.,
2009). However, the detail mechanisms by which EBERs modulate
cellular functions remained unresolved.
In this context, our study revealed that EBERs lead to transcrip-
tional downregulation of p21 WAF11/cip1 and p27kip expression and
help to override 5-FU-induced cell death in gastric (AGS) and
breast cancer (MCF7) cells. In addition, EBERs also promote cell
cycle progression in gastric cancer cells. Furthermore, to the best
of our knowledge, this is the ﬁrst report highlighting that EBERs
upregulate the activation of FAK and PAK1, downregulate theFig. 1. Stable expression of EBERs lead to chemoresistance. (A) Stable clones of AGS-EBE
expression and compared with that of EBV-positive SNU719 cells. The relative expressio
stable clones of AGS-EBERs, MCF7-EBERs and SNU719 cells against the average ΔCt values
HPRT1 as a control for RNA levels. Change in gene expression was calculated using the Δ
100%. Average7standard error obtained from three independent experiments is shown.
EBERs and SNU719 cells treated with DMSO and different concentrations of 5-FU for 24 h
EBERs and AGS-EBERLMP2A cells were administered Cisplatin at various doses for 24 h an
and MCF7 cells treated with DMSO or 5-FU or Cisplatin were stained with PI and Annex
apoptotic cells were only Annexin V-FITC positive, and live cells were both negative. The
Calibur. Results are expressed as bar graphs prepared using mean7s.e.m. of triplicate exexpression of anti-metastatic RhoGDI and KAI-1 and induces
cellular migration in gastric cancer cells. Our data strongly suggest
that EBERs-mediated upregulation of IL-6 expression and activa-
tion of its downstream molecule STAT3 are critically involved in
gastric cancer cell chemoresistance and migration.Results
EBERs lead to chemoresistance in epithelial Cancer cells
The EBERs-DNA fragment including the promoter region was
cloned into pREP7 plasmid and transfected into gastric (AGS) andRs and MCF7-EBERs were evaluated by quantitative RT-PCR for EBER-1 and EBER-2
n levels were determined by normalizing the ΔCt values of EBER-1 and EBER-2 in
for vector control cells. Primers speciﬁc for different genes were utilized along with
ΔCt method. The EBER-1 and EBER-2 expression in SNU719 cells are considered as
(B) MTT assay was done to check the cell viability of AGS, AGS-EBERs, MCF7, MCF7-
. Results are expressed as the mean7s.e.m. of triplicate experiments. (C) AGS, AGS-
d viability was measured using MTT assay. (D, E) Control and EBERs-expressing AGS
in-V tagged with FITC. Whereas the late apoptotic cells were doubly stained, early
cells were then analyzed by ﬂow cytometry using Cell Quest Pro software in FACS
periments with the representing dot plots in the inset. nnn denotes P-valueo0.001.
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EBERs-expressing stable cell clones. The plasmid pREP7 stably
transfected cells were used as vector controls. Nine stable clones of
AGS-EBERs and six of MCF7-EBERs were evaluated by quantitative
RT-PCR for EBER-1 and EBER-2 expression and compared with that
of EBV-positive SNU719 cells (data not shown). The data in Fig. 1A
showed the relative expression levels of EBERs (EBER-1 and EBER-
2) in AGS and MCF7 cells by real-time RT-PCR analysis, as
compared to that of EBV-positive SNU719 cells. Stable clones of
AGS-EBERs and MCF7-EBERs showed varying level of EBER-1 and
EBER-2 expression. The clone nos. 3 and 8 of AGS-EBERs with the
highest levels of EBER-1 (62% and 57% of the positive control level,
respectively) and EBER-2 (59% and 55% of the positive control
level, respectively) expression were selected for further experi-
ments. Similarly, clone nos. 1 and 2 of MCF7-EBERs with highest
levels of EBER-1 (49% and 55% of the positive control level,
respectively) and EBER-2 expression (47% and 52% of the positive
control level, respectively) were selected. Stable clones of hygromycin-
resistant mock vector transfectants (clones nos. 1 and 2 of AGS and
MCF7) were considered as EBERs-negative control cell lines. To
understand whether the expression of EBERs has any role in che-
moresistance, MTT assay was performed to check cell viability after
treating the EBERs-expressing clones of AGS and MCF7 as well as EBV-
positive SNU719 cells with 5-FU at different concentrations (0, 25, 50,
75, 100 mM) for 24 h. Since, EBERs and LMP2A are the limited number
of genes expressed in gastric cancer; we also checked whether the
chemoresistance can be observed in AGS cell expressing both LMP2A
and EBERs simultaneously. Additionally, AGS cells stably expressing
EBERs and EBERsLMP2A were subjected to another chemotherapeutic
agent Cisplatin at different concentrations (6, 12, 24 and 48 mM)
for 24 h. The results revealed that EBERs protect the cells not only
from the chemotherapeutic drugs 5-FU but also from Cisplatin
induced cell death (Fig. 1B and C). In order to further investigate
this apoptosis-resistance behavior of AGS-EBERs, MCF7-EBERs and
AGS- EBERsLMP2A clones, Annexin V-FITC/PI assay (Fig. 1D and E)
and cell cycle analysis (Fig. 2A and B) were done on cells treated
with 50 mM 5-FU or 12 mM Cisplatin for 24 h. The signiﬁcantly
higher (Po0.001) percentages of early (Annexin V-FITC positive)
and late (Annexin V-FITC and PI double positive) apoptotic cell
populations of 5-FU or Cisplatin treated control cells with respect
to that of EBERs-expressing cells as well as SNU719 clearly
demonstrate that EBERs protect the AGS and MCF7 cells from
chemotherapeutic drug induced apoptosis (Fig. 1D and E). It was
also evident from cell cycle phase distribution data (Fig. 2A) that
percentages of cell population in sub-G0/G1 or apoptotic phase
was 22.471.9% and 23.472.3% in 5-FU treated AGS-control clones
1 and 2, respectively, but, only 7.972.3% and 8.172.7% in 5-FU
treated AGS-EBERs clone 3 and 8, respectively. Similarly,
10.971.0% and 12.571.4% of cell population was apoptotic in 5-
FU treated MCF7-control clones 1 and 2, respectively, but, only
7.272.7% and 5.572.3% in 5-FU treated MCF7-EBERs clone 1 and
2, respectively. It may be noted that 5-FU treated EBV-positive
SNU719 cells incidentally showed only 5.471.7% of sub-G0/G1 cellFig. 2. Effect of EBERs on cell cycle. (A) The cell cycle phase distribution study of AGS-, A
for 24 h was performed by ﬂow-cytometry and the percentages of cell population in sub-
cells was determined by sub-G0/G1 cell population. The S+G2/M phase cell population i
s.e.m. of ﬁve independent experiments. Representative cell cycle histogram plots are dis
DMSO/Cisplatin treated AGS, AGS-EBERs and AGS-EBERsLMP2A are given in the bar diagr
gene expression analysis was performed using total RNA isolated from AGS cells stably
genes were utilized along with HPRT1 as a control for RNA levels. The relative expres
Average7standard error of three individual sets of experiment is shown. (D) Quantitativ
MCF7 and MCF7-EBERs cells. (E) Western blots for p21 and p27 in SNU719, AGS and AGS
from three independent experiments are shown. (F) Real-time RT-PCR to detect p21 tra
5-FU for 24 h. The relative expression levels were determined by normalizing the ΔCt valu
cells using the ΔΔCt method. Average7standard error obtained from three independentpopulation (Fig. 2A). Cisplatin treatment resulted in 4.270.9%
sub-G0/G1 population in control cells, whereas AGS-EBERs (clone
3) and AGS-EBERsLMP2A (clone 1) cells showed only 0.9970.1%
and 0.6970.1% population in the sub-G0/G1 phase. (Fig.2B). The
results of cell cycle analysis also suggested that EBERs augment
cell cycle progression, as evident by signiﬁcant higher percentages
of cell population in proliferating or S+G2/M phase of AGS-EBERs
clones. Next, we examined the effect of EBERs on the expression of
cell cycle regulatory genes, p21 and p27 by real-time RT-PCR
analysis in AGS cells. EBERs were observed to signiﬁcantly
(Po0.001) downregulate the mRNA level expression of cell cycle
inhibitors, p21 and p27 in clones 3 and 8 of AGS-EBERs and
SNU719 cells (Fig. 2C) as compared with AGS control cells. Similar
results were obtained in the real-time PCR data of MCF7-EBERs
clones (Fig. 2D). Normalizing the p21 and p27 transcript expres-
sion levels of EBERs-expressing cells against control cells showed
downregulation with signiﬁcant fold change (data not shown). The
western blot and densitometric quantiﬁcation results also indicate
that expression of p21 and p27 is indeed downregulated in EBERs-
expressing AGS and SNU719 as compared with control cells
(Fig. 2E). In addition, quantitative RT-PCR analysis was also done
to elucidate the changes in p21 transcript expression in AGS-
control and AGS-EBERs cells treated with either DMSO or 5-FU. We
noticed upregulation of p21 mRNA expression by 10.971.1 fold
(Po0.001) in 5-FU treated control cells but only 5.271.4 fold
(Po0.005) in 5-FU treated EBERs cells (Fig. 2F). Altogether, our
ﬁndings suggested that EBERs considerably contribute to chemo-
resistance.EBERs promote upregulation of IL-6 expression and its
downstream targets
In order to check whether EBERs-induced cytokine production has
any role in cellular migration and chemoresistance, we initially
examined the expression of interleukin-6 (IL-6) in EBERs-expressing
AGS and MCF7 cell clones. IL-6 transcriptional expression was
3.870.2, 3.770.3 and 7.770.5 fold higher (Po0.001) in AGS-
EBERs clones 3 and 8 and SNU719 cells, respectively, than control
AGS cells (Fig. 3A). Furthermore, IL-6 expression was 4.170.2 and
4.970.4 fold upregulated (Po0.001) in clones 1 and 2 of MCF7-EBERs
cells, respectively (Fig. 3B). To test whether IL-6 induction in AGS-
EBERs was mediated through RIG-I signaling, we transfected small
interfering RNA (siRNA) targeted to RIG-I (RIG-I siRNA) and non-
targeting negative control siRNA into AGS-EBERs clone 3 and SNU719
cells. Transcriptional results in Fig. 3C demonstrated that knockdown
of RIG-I resulted in signiﬁcant (Po0.005) downregulation of IL-6
expression in AGS-EBERs and SNU719 cells indicating that induction of
IL-6 is indeed mediated by RIG-I pathway in both these cell lines.
However, the data also suggested that RIG-I expression was not itself
altered in EBERs-expressing cells (Fig. 3C). In order to investigate
whether the IL-6 is secreted to the surrounding media, ELISA was
performed for three independent sets of cell free culture supernatantsGS-EBERs, MCF7, MCF7-EBERs and SNU719 cells treated with DMSO or 50 mM 5-FU
G0/G1 and S+G2/M phases are given in the bar diagram. The frequency of apoptotic
ndicates the percentages of proliferating cells. Results are expressed as the mean7
played. (B) The percentages of cell population in sub-G0/G1 and S+G2/M phases of
am presenting mean7s.e.m. of ﬁve independent experiments. (C) Real-time RT-PCR
expressing EBERs or empty vector and SNU719 cells. Primers speciﬁc for different
sion levels of the speciﬁed genes (p21 and p27) were determined by ΔCt values.
e transcript expression level of p21 and p27 was compared between stable clones of
-EBERs cells and mean7standard error values of densitometric quantiﬁcation done
nscript expression levels of AGS and AGS-EBERs cells treated with DMSO or 50 mM
es of other samples against the average ΔCt values for DMSO-treated vector control
experiments is shown. nn and nnn denote P-value o0.005 ando0.001, respectively.
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(Fig. 3D) are also indicative of the fact that EBERs induce IL-6 secretion
(Po0.001) in the culture media and EBERs-mediated IL-6 secretion isinhibited by RIG-I knockdown (Po0.005). In addition, RIG-I down-
stream molecule IRF3 (Samanta et al., 2008) was found to be post
translationally activated (Po0.005) in AGS-EBERs (Fig. 3E).
Fig. 3. EBERs promote upregulation of IL-6 expression. (A) Real-time RT-PCR gene expression analysis was performed to detect IL-6 transcript level expressions using total
RNA isolated from AGS cells either stably expressing EBERs or empty vector and SNU719 cells. The relative expression levels were determined by normalizing the ΔCt values
of AGS-EBERs and SNU719 cells against the average ΔCt values for vector control cells. HPRT1 was used as a control for RNA levels. Change in gene expression was calculated
using the ΔΔCt method. Average7standard error of three independent experiments is shown. (B) Quantitative RT-PCR was performed to detect the relative expression of
IL-6 gene in stable clones of MCF7, MCF7-EBERs and SNU719 cells using the ΔΔCt method. Average7standard error obtained from three individual experiments is shown.
(C) The expressions of RIG-I, IL-6 and HPRT-1 of AGS, AGS-EBERs (clone3), AGS-EBERs transfected with control siRNA or RIG-I siRNA, SNU719 transfected with control siRNA
or RIG-I siRNA are compared in mRNA level by RT-PCR. Results are representative of three individual experiments. (D) IL-6 production was measured by ELISA using the 48 h
cell-free culture supernatants of AGS control, AGS-EBERs, control siRNA and RIG-I siRNA transfected AGS-EBERs cells. The mean values7standard error obtained from three
independent experiments are shown. (E) Western blot analysis was performed from whole cell lysates of AGS, AGS-EBERs cells to detect the activation status of IRF3. Equal
loading was conﬁrmed by probing the blot for β-actin. A representative blot and the mean7s.e.m of densitometric quantiﬁcation of three independent experiments are
shown. nn and nnn denote P-value o0.005 ando0.001, respectively.
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the transcriptional expression of IL-6 target genes, uPA (Kwon et al.,
2012) and MT1-MMP (MMP-14) (Feng et al., 2010), were investi-
gated. The expression of uPA was observed to be increased
(Po0.001) by 3.970.3 and 3.670.3 folds in clones 3 and 8 of
AGS-EBERs cells. Treatment of AGS-EBERs (clone 3) with neu-IL-6 or
RIG-I siRNA downregulated (Po0.001) uPA expression to 1.770.1
fold and 1.470.4 fold, respectively (Fig. 4A and B). Similarly, uPA
expression in SNU719 cells was observed to be decreased
(Po0.001) by 2.370.2 fold and 1.970.2 fold after neu-IL-6 and
RIG-I siRNA treatment, respectively. In a similar fashion, uPA
expression was observed to be upregulated (Po0.001) by
4.170.3 fold and downregulated (Po0.001) by 1.670.2 fold and
1.570.1 fold in MCF7-EBERs, neu-IL-6 treated and RIG-I siRNA
transfected MCF7-EBERs cells, respectively (Fig. 4A and C). Expres-
sion of MMP-14 was also upregulated (Po0.001) in clones 3 and
8 of AGS-EBERs cells by 3.470.2 fold and 2.870.1 fold, respec-
tively. Upon treatment with neu-IL-6 and RIG-I siRNA theexpression decreased (Po0.001) by 2.170.2 fold and 1.670.1 fold,
respectively (Fig. 4D). Interestingly, MMP-14 mRNA expression was
also found to be downregulated (Po0.001) by 2.970.2 fold and
2.270.2 fold in neu-IL-6 and RIG-I siRNA treated SNU719 cells,
respectively. Similarly, MMP-14 transcriptional expression increased
(Po0.001) by 4.170.2 fold and decreased (Po0.001) by 1.870.1
fold and 1.570.1 fold in MCF7-EBERs, neu-IL-6 treated and RIG-I
siRNA transfected MCF7-EBERs cells, respectively (Fig. 4E).
EBERs induce IL-6 mediated STAT3 activation
Pro-inﬂammatory cytokines, like IL-6 are often found to acti-
vate STAT3 by increasing its tyrosine phosphorylation (Bromberg
and Darnell, 2000). Western blot analysis indeed showed that
STAT3 was activated in AGS-EBERs and MCF7-EBERs clones with
respect to the vector control clones (Fig. 5A, B). AGS-EBERs clone 3
(1.9770.7 fold, Po0.001) and MCF7-EBERs clone 2 (2.3670.12
fold, Po0.001) show signiﬁcantly high STAT3 activation, which
Fig. 4. EBERs upregulates the expression of IL-6 downstream genes. (A) The mRNA expression levels of uPA of control, EBERs-expressing clones and neu-IL-6, control siRNA
or RIG-I siRNA treated AGS, MCF7 cells as well as SNU719 control, neu-IL-6, control siRNA or RIG-I siRNA treated cells are shown by RT-PCR. HPRT1 was used as endogenous
gene expression control. This is a representative result of three independent experiments. Densitometric quantiﬁcation of the relative expression of uPA mRNA levels was
performed and presented by bar diagram in (B) and (C). Results are expressed as the mean7s.e.m. of triplicate experiments. (D, E) Real-time analysis of MMP-14 gene
expression of control, EBERs-expressing clones, neu-IL-6 treated and control siRNA or RIG-1 siRNA transfected AGS, MCF7 and SNU719 cells was performed using the ΔΔCt
method. Average7standard error obtained from three independent sets of experiments is shown. nn and nnn denote P-value o0.005 ando0.001, respectively.
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EBERs and STAT3 activation. Moreover, treatment of AGS-control
(clone 1) cells with cell-free conditioned media obtained from
AGS-EBERs (clone 3) cells grown for 48 h stimulated STAT3
activation within 6 h of treatment (Po0.005) (Fig. 5C). The result
indicated the involvement of soluble factors in triggering STAT3
activation. Additionally, the data in Fig. 5D and E demonstrated
that treatment of neutralizing IL-6 antibody at a concentration of
1 mg/ml downregulated STAT3 activation both in AGS-EBERs and
SNU719 cells in a time dependent manner.
Activated STAT3 regulates chemoresistance and invasiveness of
EBERs-expressing cells
In order to examine whether the expression of IL-6 actually
contributed to chemoresistance and cellular migration of EBERs-
expressing cells, we performed cell cycle analysis and in vitro
matrigel assay. AGS-control clone 1, AGS-EBERs clone 3, AGS-
EBERs treated with neu-IL-6 and AGS-EBERs clone 3 transfected
with dnSTAT3β cells were treated with either DMSO or 5-FU
(50 mM) for 24 h before cells were harvested for cell cycle analysis
by ﬂow-cytometry. Sub-G0/G1 or apoptotic cell populations were
plotted in Fig. 6A to evaluate the apoptosis-inducing effects ofneutralizing anti-IL-6 antibody or dnSTAT3β on AGS-EBERs cells in
the presence or absence of 5-FU. Apoptosis of 5-FU treated AGS-
EBERs cells was triggered by neutralizing anti-IL-6 antibody as
evident by increased sub-G0/G1 cell populations (Po0.005).
Supportively, dnSTAT3β transfection, instead of neutralizing IL-6,
also showed similar apoptotic phenomenon (Po0.005) in AGS-
EBERs cells treated with 5-FU (Fig. 6A). Similarly, 5-FU was
observed to increase the apoptotic cell population in SNU719 cells
only after pre-treatment with neutralizing IL-6 or dnSTAT3β
transfection (Fig. 6A). In order to further extend the cell cycle
studies, we then measured the transcriptional expression of cell
cycle inhibitors, p21 and p27. These cyclin-dependant kinase
inhibitors (CDKI) were observed to be upregulated in dnSTAT3β
transfected AGS-EBERs cells (Po0.001) as compared to AGS-EBERs
clone 3 cells and dnSTAT3β transfected SNU719 cells as compared
to SNU719 cells (Fig. 6B). Additionally, p21 and p27 transcriptional
expression levels were also observed to be increased in dnSTAT3β
transfected MCF7-EBERs cells as compared to MCF7-EBERs clone
2 cells (Fig. 6C).
The invasive potential of EBERs was evaluated using both
in vitro matrigel assay and wound healing scratch assay. The
in vitromatrigel invasion assay (Fig. 7A and B) revealed that EBERs
signiﬁcantly (Po0.005) induce cellular invasion (2.770.3 fold and
Fig. 6. Activated STAT3 regulates chemoresistance in EBERs-expressing AGS cells. (A) The bar diagram is showing the average7standard error values obtained from ﬁve
individual experiments of the percentages of cell population in sub-G0/G1 phase of cell cycle of AGS, AGS-EBERs, AGS-EBERs with neu-IL-6 treatment and AGS-EBERs
transfected with dnSTAT3β and SNU719, neu-IL-6 treated SNU719 and dnSTAT3β transfected SNU719 cells treated with DMSO or 5-FU for 24 h, as evident by cell cycle
analysis by ﬂow cytometry. (B) Real-time RT-PCR gene expression analysis was performed to detect transcript level expressions of p21 and p27 using total RNA isolated from
AGS, AGS-EBERs, dnSTAT3β transfected AGS-EBERs, SNU719 and dnSTAT3β transfected SNU719 cells. Average7standard error of three individual experiments is shown.
(C) Transcriptional analysis was performed to detect expressions of p21 and p27 using total RNA isolated from MCF7, MCF7-EBERs, dnSTAT3β transfected MCF7-EBERs cells.
The relative expression levels were determined by normalizing the ΔCt values of EBERs-expressing and dnSTAT3β transfected EBERs-expressing cells against the average ΔCt
values for control cells for p21 and p27. HPRT1 was used as a control for RNA levels. Changes in gene expression were calculated using the ΔΔCt method. Average7standard
error of three independent experiments is shown. nn and nnn denote Po0.005 and Po0.001, respectively, as obtained by t test.
Fig. 5. EBERs induce IL-6 mediated STAT3 activation. Western blot analysis was performed from whole cell lysates of stable clones of AGS, AGS-EBERs (A) and MCF, MCF7-
EBERs (B) to detect the activation status of STAT3. Equal loading was conﬁrmed by probing the blot for total STAT3. (C) Western blots are representing the pSTAT3 and STAT3
levels of AGS cells after trans-applying the cell free culture supernatant collected from 48 h grown AGS-EBERs cells for speciﬁed time periods. (D) Western blots are showing
the pSTAT3 and STAT3 status of AGS-EBERs treated with neu-IL-6 antibody for 6 h and 12 h. (E) Western blots are showing the pSTAT3 and STAT3 status of SNU719 cells
treated with neu-IL-6 antibody for 6 h and 12 h. A representative blot and the mean7s.e.m of densitometric quantiﬁcation of three independent experiments are shown in
each case. n, nn and nnn denote P-value o0.05, o0.005 ando0.001, respectively.
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cells as compared to the vector control cells. Additionally cell
mobility study using in vitromatrigel invasion assay (Fig. 7A and B)
indicated that the numbers of invading cells were signiﬁc-antly (Po0.005) decreased by 1.770.1 fold in neu-IL-6 treated
AGS-EBERs cells. The same was also true for dnSTAT3β transfected
AGS-EBERs cells as compared to AGS-EBERs cells (Po0.005)
(Fig. 7A and B). Moreover, scratch assay manifests an increase in
Fig. 7. Activated IL-6-STAT3 pathway regulates invasiveness of EBERs-expressing AGS cells. (A) AGS, AGS-EBERs, AGS-EBERs cells treated with neu-IL-6 and dnSTAT3β
transfected AGS-EBERs cells were added into BioCoat matrigel invasion chamber and incubated for 22 h. The invading cells migrated on the lower surface by penetrating
through the matrigel. The cells on the undersurface of the membrane were stained with Haematoxylin and then visualized and photographed at 100 magniﬁcation using a
phase-contrast light microscope. Small black dots are the pores of the ﬁlter membrane. The photographs are representative of different microscopic ﬁelds from three
independent experiments. (B) After staining, the quantiﬁcation of the number of invading cells was done. Results are expressed as the mean7s.e.m. of the number
of invaded cells as visualized under ﬁve different microscopic ﬁelds of triplicate membranes for each set of samples. (C) Wound healing Scratch assay. Conﬂuent monolayers
of AGS, AGS-EBERs and AGS-EBERsLMP2A were scratched with a 200 μl tip and images were acquired at 0, 24 and 48 h in a phase contrast microscope under 10
magniﬁcation. (D) Quantitation of closure of the wound at 24 and 48 h. The results shown are a representation of N≥6. (E, F) Western blots showing the levels of pFAK, pPAK1,
RhoGDI and KAI-1 in whole cell lysates of stable clones of AGS and AGS-EBERs cells. Equal loading was conﬁrmed by probing blots for β-actin. A representative blot and the
mean7s.e.m of densitometric quantiﬁcation of three independent experiments are shown in each case. n, nn and nnn denote Po0.05, Po0.005 and Po0.001, respectively, as
obtained by t test.
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EBERsLMP2A (Fig. 7C and D). AGS-EBERs (clone 3) shows
30.370.7% and 50.170.6% closure and AGS-EBERsLMP2A (clone
1) shows 42.370.1% and 75.671.1% closure at 24 and 48 h,
respectively, compared to AGS control cells which show only
1.2770.07% closure at 24 h and 16.270.2% closure at 48 h.
Furthermore, EBERs also induce the activation of pFAK and pPAK1
and downregulate the expression of two metastasis-suppressors,
RhoGDI and KAI-1, as evident by western blot analysis (Fig. 7E
and F).Discussion
EBERs are the only EBV latency gene products that are consistently
expressed at high levels in all EBV-associated tumors (Kieff et al.,
2007). Earlier reports indicate that EBERs induce the expression of
several autocrine growth factors (Dutta et al., 2006; Iwakiri et al.,
2005; Kitagawa et al., 2000; Samanta et al., 2008; Wu et al., 2007;
Yang et al., 2004) and confer resistance to different apoptotic stimuli
(Komano et al., 1999; Nanbo et al., 2005; Wong et al., 2005). In this
study, we tried to understand the exact role of EBERs-expression in
epithelial cancer particularly in EBV-negative gastric and breast cancer
cell lines, AGS and MCF7, respectively. Cell cycle distribution patterns
revealed that the percentages of cell population in S+G2/M-phase
were higher in EBERs-expressing AGS cells corroborating the earlier
report that EBERs promote cell proliferation (Iwakiri et al., 2005).
EBERs were also shown to protect both AGS and MCF7 cells against
the chemotherapeutic drug 5-FU induced cell death. Moreover, EBV-
positive SNU719 cells also showed apoptosis-resistance when treated
with 50 mM 5-FU for 24 h. Resistance to cisplatin as observed in AGS-
EBERs and AGS-EBERsLMP2A further sheds light on the chemopro-
tecting ability of EBERs. In addition, EBERs were shown to deregulate
the transcriptional expression of cell cycle inhibitors, p21 and p27 in
AGS and MCF7 cells; p27 acts to inhibit G1-to-S phase transition (Lee
and Kim, 2009) while p21 arrests cell cycle progression through S, G2
and G2/M (Abbas and Dutta, 2009). Additionally, the mRNA level
expression of p21 and p27 in SNU719 cells were also observed to be
signiﬁcantly lower with respect to EBERs-negative gastric cancer cells.
Incidentally, the upregulation of p21 expressionwas found to be much
lower in 5-FU-treated AGS-EBERs cells than that of AGS control cells,
suggesting that downregulation of p21 may contribute in the observed
5-FU resistance of AGS-EBERs cells.
Often there is a strong association between chronic inﬂamma-
tion and neoplastic diseases. Interestingly, our data demonstrated
that the level of IL-6 production and the activation of its down-
stream effector STAT3 were considerably higher in gastric and
breast cancer cells stably transfected with EBERs as well as in EBV-
positive SNU719 cells. We hypothesized that aberrant activation of
STATs may contribute to the critical biological responses of EBERs
in epithelial cancer cells. STATs are a family of transcriptional
factors that are activated by various pro-inﬂammatory cytokines
like IL-6 and are essential in regulating differentiation, cell-cycle
progression and cancer development (Bromberg and Darnell,
2000). On the other hand, pSTAT3Y705 level was decreased by
adding neutralizing antibody against IL-6 to AGS-EBERs and
SNU719 cells. Moreover, trans-supplying cell free supernatant of
AGS-EBERs cells was also shown to enhance the phosphorylation
of STAT3 in control gastric cancer cells; these results therefore
support the idea that EBERs expression upregulates IL-6 secretion
which can act as an autocrine growth factor (Yokoi et al., 1990).
There are compelling evidences that EBERs-mediated activation of
RIG-I results in the production of type I IFN and IL-10 (Samanta
et al., 2006, 2008). Our study suggests that EBERs induce IL-6
expression through RIG-I, as RIG-I knockdown by speciﬁc siRNA
resulted in the downregulation of IL-6 production. Similarobservation in SNU719 cells conﬁrms this mechanism. Moreover,
EBERs were observed to activate RIG-I downstream effector IRF3 in
AGS cells. Previous report suggested that EBERs can cooperate
with LMP1 to induce IL-6 in LCL (Wu et al., 2007). This study
provides the ﬁrst report suggesting that EBERs alone can induce
IL-6 expression. Furthermore, signiﬁcant upregulation of IL-6
target genes, uPA and MMP-14 were obtained in EBERs-
expressing clones of AGS and MCF7, while administration of either
neu-IL-6 antibody or transfection of RIG-I siRNA resulted in
downregulation of their expression, as well as in EBV positive
SNU719 cells itself. Altogether, our results indicate the probable
function of EBERs in inducing IL-6 expression through the RIG-I
pathway.
We have used neutralizing IL-6 antibody and dominant-
negative STAT3β plasmid to assess the involvement of the activa-
tion of STAT3 by EBERs to promote chemoresistance and cellular
migration. Neu-IL-6 and dnSTAT3β treatments exhibit signiﬁcant
apoptosis induction in 5-FU-treated AGS-EBERs and SNU719 cells.
Moreover, dnSTAT3β treatment can upregulate the transcriptional
expression of p21 and p27, suggesting the probable role of EBERs-
induced STAT3 activation in repressing p21 and p27 transcription
in AGS and MCF7 cells. The transcriptional expression of p21 and
p27 was also observed to be downregulated in dnSTAT3β trans-
fected SNU719 cells. In addition, neu-IL-6 and dnSTAT3β treat-
ments also inhibit the invasion of AGS-EBERs cells. This ﬁnding
supports the previous reports showing that in gastric cancer cells,
overexpression of IL-6 promotes cell motility and invasiveness (Lin
et al., 2007) and constitutively activated STAT3 is strongly corre-
lated with gastric tumor invasion (Yakata et al., 2007).
In addition, our study revealed that EBERs induce the activation
of pro-metastatic molecules pFAK and pPAK1 along with down-
regulation of the expression of two anti-metastatic molecules
RhoGDI and KAI-1. Previous studies have reported that upregula-
tion pFAK has been implicated in cell motility through activation of
Rho GTPases (Tomar and Schlaepfer, 2009). Moreover, PAK-1 acts
as a downstream target of the Rho family GTPases (Arias-Romero
and Chernoff, 2008) and is also involved in regulating tumor
metastasis (Carter et al., 2004). Additionally, Rho GTPases are
regulated by RhoGDI, a metastatic suppressor, which can prevent
nucleotide exchange and membrane association of Rho GTPases
(Dovas and Couchman, 2005). So, EBERs-mediated suppression of
RhoGDI may synergistically work with the activation FAK and PAK-
1 to promote cell migration. Another cell membrane associated
metastasis-suppressor KAI1/CD82, belonging to tetraspanin family,
interacts with integrins and receptor-tyrosine kinases to attenuate
Ras-Cdc42/Rac signaling responsible for cell adhesion and migra-
tion (Berditchevski, 2001; Takahashi et al., 2007). Thus, EBERs-
induced downregulation of KAI-1 expression along with activated
PAK1 may also help to promote cell migration. Interestingly, this
ﬁnding corroborates the recent clinical report indicating the associa-
tion of EBV in highly metastatic gastric carcinoma (BenAyed-Guerfali
et al., 2011; Truong et al., 2009).
Despite intense research, relatively few EBERs-regulated genes
have been clearly characterized so far. This is the ﬁrst report
suggesting a novel involvement of EBERs-induced activation of IL-
6-STAT3 signaling pathway in chemoresistance and cellular migra-
tion of EBERs-expressing gastric cancer cells.Material and methods
Materials
5-Fluorouracil was purchased from Sigma–Aldrich (St. Louis, MO)
and dissolved in DMSO. The anti-FAKpY397, anti-PAK1/2pT423/
T402, anti-RhoGDI, anti-IRF3pY396, anti-STAT3pY705, anti-STAT3,
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mouse horseradish peroxidase (HRP)-conjugated secondary anti-
bodies were purchased from Cell Signaling Technology (Beverly,
MA). The anti-KAI-1, anti-p21 and anti-p27 primary antibodies
were procured from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA). Rat anti-human IL-6 neutralizing antibody and rat IgG1κ
isotype control antibodies were obtained from BD Biosciences
(San Jose, CA).
Cell culture
Human gastric cancer cell lines, EBV-negative AGS and EBV-
positive SNU719 (Korean Cell Line Bank) were maintained in RPMI
1640 (Gibco, Carlsbad, CA) supplemented with 10 v/v% heat
inactivated fetal bovine serum (FBS) in 5% CO2 humidiﬁed atmo-
sphere at 37 1C. EBV-negative human breast cancer cell line, MCF7
was grown in DMEM (Gibco, Carlsbad, CA). In addition, the cell
free culture supernatant was prepared from 48 h grown AGS-
EBERs culture by passing through 0.22 mm ﬁlter (Millipore, Bill-
erica, MA) to treat non-EBERs control cells, as and when required.
DNA constructs and transfection
The EBERs-DNA fragment including the promoter region was
generated from the EBV-DNA present in the prototype B95-8 strain
by PCR ampliﬁcation (5′-ATATGTCGACGTCTCGGAGCTCCTAGGTCA-
GAC-3′ and 5′-ATATGTCGACATGCATATACAGTCAGCATATG-3′). The
1171 bp EBERs open reading frame (ORF) fragment was inserted
into the SalI-digested pREP7 vector (Invitrogen, Carlsbad, CA) to
produce EBERs/pREP7. A dominant negative STAT3β-Y705F plas-
mid construct was a kind gift from Prof. J. Clifford (Meso Scale
discovery, New York). The plasmids were transfected into the cells
were using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Stable
clones of transfectants expressing only vector or EBERs were
selected in medium containing 400 mg/ml hygromycin (Gibco,
Carlsbad, CA) and screened for the quantitative expression levels
of EBER-1 and EBER-2. AGS-EBERLMP2A clones were generated by
doubly transfecting AGS with pREP7 vector containing EBERs and
pcDNA containing the LMP2A cDNA. Stable clones expressing both
EBERs and LMP2Awere selected with 400 mg of hygromycin (Invitro-
gen, Carlsbad, CA) and 800 mg of G418 (Gibco, Carlsbad, CA).
RT-PCR & Quantitative RT-PCR
Total RNA was extracted using Tripure isolation reagent (TRIZOL,
Roche, Mannheim, Germany) and quality assayed using RNA gel
electrophoresis as well as spectroscopy (Eppendorf BioPhotometer,
Hamburg, Germany). 5 μg of RNA was subsequently treated with
RNAse free DNAse (DNAfreeTM Ambion, Austin, TX) and reverse
transcribed for 90 min at 42 1C using random hexamer primers and
M-MuLV reverse transcriptase (Fermentas, Burlington, Ontario). To
detect the expression of EBERs, 1 μl of cDNA was subjected to PCR in
a 20 μl reaction volume using 1 U of recombinant Taq polymerase
(Bioline, Taunton, MA) and keeping the Tm at 60 1C. The β-actin gene
was used as an internal control. The ampliﬁed PCR products were
electrophoresed and visualized after staining the agarose gels to
detect the presence or absence of EBERs and mRNA expression levels
of IL-6 (609 bp product size), RIG-I (110 bp product size), uPA (349 bp
product size) and β-actin (315 bp product size). The primer sequences
were as follows: (a) IL-6, 5′-CTTCGGTCCAGTTGCCTTCT-3′ (sense
primer) and 5′- AGGAACTCCTTAAAGCTGCG-3′ (antisense primer);
(b) RIG-I, 5′- TGTGCTTCTCTTGATGCGTCA-3′ (sense primer) and 5′-
ATCCGTGATTCCACTTTCCTGA-3′ (antisense primer); (c) uPA, 5′-TGTG
AGATCACTGGCTTTGG-3′ (sense primer) and 5′-AGGCCATTCTCT
TCCTTGGT-3′ (antisense primer) and (d) β-actin, 5′-GAA GCA TTTGCG GTG GAC CAT-3′ (sense primer) and 5′-TCC TGT GGC ATC CAC
CAA ACT-3′ (antisense primer).
Quantitative RT-PCR was performed using SYBR Green core PCR
reagents (Applied Biosystems, Framingham. MA) and HPRT1 as the
endogenous control. The qRT-PCR reactions and analyses were carried
out in 7500 Sequence Detection System (Applied Biosystems). The
primer sequences were as follows: (a) EBER-1, 5′-AAAACATGCG-
GACCACCA-3′ (sense primer) and 5′-AGGACCTACGCTGCCCTA-3′
(antisense primer); (b) EBER-2, 5′-CCGTTGCCCTAGTGGTTTC-3′
(sense primer) and 5′-GCGGACAAGCCGAATACC-3′ (antisense pri-
mer); (c) p21, 5′-CTGGAGACTCTCAGGGTCGAA-3′ (sense primer) and
5′–GCGGATTAGGGCTTCCTCTT-3′ (antisense primer); (d) p27, 5′-TGAT
CCGTCGGACAGCCAGA-3′ (sense primer) and 5′-CCGTCTGAAACATT
TTCTTCTGT-3′ (antisense primer); (e) MMP-14; 5′-CATTGGAGGAGACA
CCCACT-3′ (sense primer) and 5′-TGGGGTTTTTGGGTTTATCA-3′
(antisense primer) and (f) HPRT1, 5′-GACACTGGCAAAACAATGC
AGAC-3′ (sense primer) and 5′-TGGCTTATATCCAACACTTCGTGG-3′
(antisense primer).
RIG-I knockdown using small interfering RNAs
Sigma MISSIONs siRNA (siRNA ID: SASI_Hs01_00047980) tar-
geting human RIG-I (NM_014314) was used to block RIG-I mRNA
expression. Non-targeting negative control siRNA (Sigma, St. Louis,
MO) was used to rule out non-speciﬁc or off-target effects. Double-
stranded siRNAs (20 nM) were transfected into 2105 cells using
N-ter Nanoparticle Si RNA trasfection reagent (Sigma, St. Louis,
MO) according to the manufacturer’s protocols. Transiently trans-
fected cells were grown for 48 h before collecting total cellular
RNA to carry out RT-PCR experiments.
MTT assay
For MTT assay the required cells were cultured in 6-well plate
and incubated in the presence or absence of DMSO or different
concentrations of 5-FU at 37 1C, 5%CO2 for 24 h. Then 20 ml of MTT
solution (5 mg/ml) was added to each well and incubated for 3 h.
Yellow colored MTT (4,5 dimethyl azol)2,5 diphenyl tetrazolium
bromide) (Sigma, St. Louis, MO) is reduced to purple colored
Formazan by active reductase enzymes present in living cells.
The insoluble purple formazan product was then dissolved in MTT
solvent DMSO to produce a colored solution. Then absorbance of
this colored solution was measured at 560 nm wavelength by a
spectrophotometer (Eppendorf, Hamburg, Germany).
Annexin V-FITC/PI assay
The Annexin V-ﬂuorescein isothiocyanate (FITC) conjugate was
used in conjunction with PI to discriminate among the live (Annexin
V-FITC and PI negative), early apoptotic (Annexin V-FITC positive and
PI negative) and necrotic (Annexin V-FITC and PI double positive) cells.
Cells were assessed for binding with Annexin V-FITC and PI using the
FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, San Jose, CA)
following the manufacturer’s protocol. The percentage of apoptotic
cells was determined by ﬂow cytometry using Cell Quest Pro software
in FACS Calibur (Becton Dickinson, San Jose, CA). A total of 10,000
events were acquired for analysis. FL1-Log (x-axis; FITC-ﬂuorescence)
versus FL-2 log (y-axis, PI) were recorded and displayed.
Cell cycle analysis
Cell cycle analysis of cultured cells was done by ﬂow cytometry.
Mock transfected and EBERs-expressing cells were cultured in the
presence of 50 M 5-FU or DMSO for 24 h in a humidiﬁed CO2 (5%)
incubator at 37 1C. Cells were harvested by trypsinization and ﬁxed
with pre-chilled 70% ethanol. After centrifugation at 1000 g, cells
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37 1C for 1 h. Finally, cells were incubated with propidium iodide
(PI) (BD Biosciences, San Jose, CA) to a ﬁnal concentration of 40 mg/
ml for 15 min in dark at room temperature and Cell cycle phase
distribution of nuclear DNA was determined by Cell Quest Pro
software in FACS Calibur (Becton Dickinson, San Jose, CA). A total
of 10,000 gated events were acquired for analysis. Histogram of
FL2-A (x-axis; PI-ﬂuorescence) versus counts (y-axis) was recorded
and displayed.
Enzyme-linked immunosorbent assay
For the enzyme-linked immunosorbent assay (ELISA), AGS
control, AGS-EBERs and control siRNA or RIG-I siRNA-transfected
AGS-EBERs cells (1106 cells) were cultured in 1 ml of complete
medium for 48 h. The cell free culture supernatants were har-
vested, and the amount of IL-6 in the culture supernatants was
determined using BioLegend’s (San Diego, CA) ELISA MAX™
Deluxe Set sandwich ELISA kit (kindly provided by Dr. Jayati
Mookerjee Basu, Chittaranjan National Cancer Institute, Kolkata,
India) following the manufacturer’s protocol.
Western blot analysis
Cells were harvested, lysed in Nonidet P-40-lysis buffer [20 mM
Tris–HCl (pH 8.0), 137 mM NaCl, 10% glycerol, 1% NonidtP-40, 2 mM
EDTA, 1 mM Na3VO4, 50 mM phenylmethylsulfonyl ﬂuoride, 10 mg/
ml leupeptin, 10 mg/ml aprotinin, protease inhibitor cocktail
(Roche, Mannheim, Germany) and phosphatase inhibitor (Roche,
Mannheim, Germany)] for 30 min on ice, and centrifuged at
14,000 g for 5 min at 4 1C and the supernatant was collected.
Equal amounts of protein (25–50 mg) were subjected to 8% SDS-
polyacrylamide gel electrophoresis and electrotransferred onto
nitrocellulose membrane (GE Healthcare, USA). The protein blot
in the membrane was blocked with 5% BSA in TBS containing 0.1%
Tween 20 (Sigma Chemical Co., St. Louis, MO) for 1 h at room
temperature. Primary antibodies as indicated were incubated with
membranes for 4 1C overnight, and the membranes were washed
in TBS-T, probed with horseradish peroxidase–conjugated second-
ary antibodies (Cell Signaling Technology, Beverly, MA) for 1 h
(1:3000 dilution in TBS-T), and then washed with TBS-T. The
antibody-bound protein bands were detected with enhanced che-
miluminescence reagent (Amersham Biosciences, Pittsburgh, PA)
and photographed and quantitated using VersaDoc chemilumines-
cence detector & Quantity ONE software (Bio-Rad, Hercules, CA).
Invasion assay
BioCoat Matrigel Invasion chambers (BD Biosciences, San Jose,
CA) were allowed to reach room temperature. Warm (37 1C) RPMI
1640 medium was added to the interior of the inserts (2 ml each)
and wells (2 ml each). Rehydration for 2 h in humidiﬁed culture
incubator (37 1C, 5% CO2 atmosphere) was followed by careful
removal of media without disturbing the layer of Matrigel Matrix
on the membrane rehydrated basement membrane covering a
Matrigel preparation with a diameter of 8 mm. An equal number
(3105) of cells were resuspended in 2 ml of serum-free RPMI
1640 medium containing 0.2% BSA and plated on the Matrigel-
coated upper surface of the ﬁlter membrane in each insert. The
growth medium containing 10% FBS was used as a chemoattrac-
tant in the bottom well. According to the manufacturer’s instruc-
tion, after 22 h of incubation, non-invading cells were removed
from the upper surface of the membrane by scrubbing with a
cotton swab. Cells that invaded into the Matrigel were migrated
out onto the lower surface of the membrane. Cells on the lower
surface of the membrane were then ﬁxed in pre-chilled 100%methanol and stained with Hematoxylin solution. Several ﬁelds of
stained cells per ﬁlter were counted under a phase-contrast light
microscope and photographed at 100 magniﬁcation. Results are
expressed as the mean7s.e.m. of the number of invaded cells as
visualized under ﬁve different microscopic ﬁelds of triplicate
membranes for each set of samples.
Wound healing Scratch assay was performed on fully conﬂuent
monolayers. A scratch or wound was introduced with the help of a
200 μl tip. Images were then acquired at 0, 24 and 48 h in a phase
contrast microscope under 10 magniﬁcations. Distances were
measured using Image J software (National Institute of Health) and
cell invasion was represented as percentage (%) closure.
Statistical analysis
Results obtained from multiple experiments were reported as
the mean7s.e.m. The data were analyzed for signiﬁcance by
standard student’s t test. The gene expression levels were com-
pared by unpaired two-tailed t test. Only Po0.05 was considered
statistically signiﬁcant.Acknowledgments
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